RecruitingNCT07428460
Accelerated neuromodulation for negative symptoms of schizophrenia
About this title
Read the official source — NCT07428460Device studyAges 18–65Canada
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What will I do during this study?
Participants receive active or sham (simulated) theta-burst stimulation over five consecutive days, with ten sessions each day. Active treatment uses one of two methods to target the left prefrontal cortex.
- Listed locations
- Montreal and 2 more locationsSee all locations and recruitment
- Treatment duration
- Five consecutive days of stimulation, with 10 sessions each day
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 1, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 75
- Sponsor
- Douglas Mental Health University Institute
- Sponsor type
- University
- Study type
- Device
- Intervention type
- Device
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07428460
- Official title
Show the full official title
Accelerated, Neuronavigated Neuromodulation Therapy for Negative Symptoms of Schizophrenia
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Montreal · Québec · Verdun
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Douglas Mental Health University Institute, a university.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
